{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:01:17Z","timestamp":1791896477185,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503091"],"award-info":[{"award-number":["81503091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21572010"],"award-info":[{"award-number":["21572010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21772005"],"award-info":[{"award-number":["21772005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PUMC Youth Fund and the Fundamental Research Funds for the Central Universities","award":["2017350002"],"award-info":[{"award-number":["2017350002"]}]},{"name":"General Financial Grant from the China Postdoctoral Science Foundation","award":["2015M570906"],"award-info":[{"award-number":["2015M570906"]}]},{"name":"Postdoctoral Grant of Peking University-Tsinghua University Center for Life Science"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmech.2018.08.037","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T19:26:45Z","timestamp":1534274805000},"page":"887-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-6247","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Ren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Rong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.08.037_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2018.08.037_bib2","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib3","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib4","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib5","first-page":"651","article-title":"Stats: transcriptional control and biological impact, Nature reviews","volume":"3","author":"Levy","year":"2002","journal-title":"Molecular cell biology"},{"key":"10.1016\/j.ejmech.2018.08.037_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.21037\/hbsn.2016.03.02","article-title":"STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCC","volume":"5","author":"Ghoshal","year":"2016","journal-title":"Hepatobiliary Surgery and Nutrition"},{"key":"10.1016\/j.ejmech.2018.08.037_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/bc.2011.038","article-title":"STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter","volume":"392","author":"Zugowski","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib8","first-page":"4497","article-title":"IL-6 regulates MMP-10 expression via JAK2\/STAT3 signaling pathway in a human lung adenocarcinoma cell line","volume":"29","author":"Zhang","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cellsig.2008.02.017","article-title":"HER2-dependent MMP-7 expression is mediated by activated STAT3","volume":"20","author":"Yuan","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2018.08.037_bib10","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1074\/jbc.M707429200","article-title":"Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function","volume":"283","author":"Cheng","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib11","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-05-2203","article-title":"Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3","volume":"66","author":"Leslie","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.onc.1209149","article-title":"Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells","volume":"25","author":"Itoh","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-04-1752","article-title":"Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells","volume":"12","author":"Gritsko","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib14","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1038\/sj.onc.1207383","article-title":"Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis","volume":"23","author":"Xie","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib15","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1073\/pnas.0404100101","article-title":"Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C","volume":"101","author":"Dechow","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.08.037_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","article-title":"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib17","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.189.1.63","article-title":"STAT3 is required for the gp130-mediated full activation of the c-myc gene","volume":"189","author":"Kiuchi","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2018.08.037_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182282","article-title":"Correlation between p-STAT3 overexpression and prognosis in lung cancer: a systematic review and meta-analysis","volume":"12","author":"Tong","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.08.037_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ijc.29799","article-title":"STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer, International journal of cancer","volume":"138","author":"Permuth-Wey","year":"2016","journal-title":"J.\u00a0Int. Cancer"},{"key":"10.1016\/j.ejmech.2018.08.037_bib21","first-page":"20014","article-title":"Overexpression of STAT3\/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis","volume":"8","author":"He","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2018.08.037_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.eururo.2012.09.052","article-title":"STAT3 polymorphism can predict the response to interferon-alpha therapy in patients with metastatic renal cell carcinoma","volume":"63","author":"Eto","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib23","first-page":"28","article-title":"Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer","volume":"12","author":"Dobi","year":"2013","journal-title":"Clin. Colorectal Canc."},{"key":"10.1016\/j.ejmech.2018.08.037_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1447-0756.2009.01131.x","article-title":"Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy","volume":"36","author":"Choi","year":"2010","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1078-0432.CCR-04-1749","article-title":"Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression","volume":"12","author":"Diaz","year":"2006","journal-title":"Clin. Canc. Res.: Off. J. Am. Assoc. Can. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib26","first-page":"5772","article-title":"JAK2\/STAT3 pathway as a therapeutic target in ovarian cancers","volume":"15","author":"Yoshikawa","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejmech.2018.08.037_bib27","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/cancers6041986","article-title":"STAT3: a novel molecular mediator of resistance to chemoradiotherapy","volume":"6","author":"Spitzner","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2018.08.037_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/bjoc.2001.1942","article-title":"IL-6 gene amplification and expression in human glioblastomas","volume":"85","author":"Tchirkov","year":"2001","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2018.08.037_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas","volume":"100","author":"Colomiere","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2018.08.037_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1593\/neo.06274","article-title":"Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma","volume":"8","author":"Squarize","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2018.08.037_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046892","article-title":"The Wnt\/beta-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells","volume":"7","author":"Fragoso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.08.037_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1158\/1535-7163.MCT-12-0550","article-title":"Suppression of survivin induced by a BCR-ABL\/JAK2\/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs","volume":"12","author":"Stella","year":"2013","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.08.037_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1590\/1414-431X20133003","article-title":"Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer","volume":"46","author":"Sheng","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2016.01.131","article-title":"Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling","volume":"470","author":"Yan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.08.037_bib35","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3892\/ijo.2016.3442","article-title":"Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K\/Akt signaling pathways","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib36","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.4238\/2015.March.30.3","article-title":"Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in\u00a0vitro","volume":"14","author":"Tang","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2013.08.022","article-title":"Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer","volume":"341","author":"Ji","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2018.08.037_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543780802565791","article-title":"Targeting STAT3 in cancer: how successful are we?","volume":"18","author":"Yue","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2018.08.037_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/156800907780006922","article-title":"Small molecule inhibitors of Stat3 signaling pathway","volume":"7","author":"Deng","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2018.08.037_bib40","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/jm300207s","article-title":"Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein","volume":"55","author":"Debnath","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ajh.21785","article-title":"TG101209, a novel JAK2 inhibitor, has significant in\u00a0vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells","volume":"85","author":"Ramakrishnan","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib42","first-page":"1209","article-title":"Stat3-siRNA induces Fas-mediated apoptosis in\u00a0vitro and in\u00a0vivo in breast cancer","volume":"34","author":"Kunigal","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"Hedvat","year":"2009","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2018.08.037_bib44","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1158\/0008-5472.CAN-07-0593","article-title":"WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells","volume":"67","author":"Ferrajoli","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1349-7006.2006.00340.x","article-title":"Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in\u00a0vitro","volume":"97","author":"Huang","year":"2006","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejmech.2018.08.037_bib46","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.bmcl.2008.08.032","article-title":"Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening","volume":"18","author":"Hao","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.037_bib47","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.08.037_bib48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib49","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1073\/pnas.0409894102","article-title":"A\u00a0low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.08.037_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1535-7163.261.3.3","article-title":"Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity","volume":"3","author":"Turkson","year":"2004","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.08.037_bib51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0960-894X(02)01050-8","article-title":"Identification of a high-affinity phosphopeptide inhibitor of Stat3","volume":"13","author":"Ren","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.037_bib52","doi-asserted-by":"crossref","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib53","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1101\/gad.1553707","article-title":"Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB","volume":"21","author":"Yang","year":"2007","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2018.08.037_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0065-230X(08)60835-0","article-title":"SH2 and SH3 domains in signal transduction","volume":"64","author":"Pawson","year":"1994","journal-title":"Adv. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.08.037_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(95)90406-9","article-title":"Modular binding domains in signal transduction proteins","volume":"80","author":"Cohen","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.08.037_bib56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/2159-8290.CD-12-0191","article-title":"First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy","volume":"2","author":"Sen","year":"2012","journal-title":"Canc. Discov."},{"key":"10.1016\/j.ejmech.2018.08.037_bib57","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/cb500071v","article-title":"A\u00a0small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion","volume":"9","author":"Huang","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/onc.2015.419","article-title":"Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in\u00a0vivo","volume":"35","author":"Huang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","article-title":"Pharmacophore modeling and applications in drug discovery: challenges and recent advances","volume":"15","author":"Yang","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.08.037_bib61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2013.04.087","article-title":"Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells","volume":"435","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.08.037_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.08.037_bib63","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2018.08.037_bib64","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.08.037_bib65","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4155\/fmc-2017-0308","article-title":"Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition","volume":"10","author":"Comsa","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.037_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14715\/cmb\/2018.64.6.4","article-title":"Luteolin promotes the sensitivity of cisplatin in ovarian cancer by decreasing PRPA1-medicated autophagy","volume":"64","author":"Liu","year":"2018","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/IGC.0000000000000014","article-title":"Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary","volume":"24","author":"Itamochi","year":"2014","journal-title":"Int. J. Gynecol. Canc."},{"key":"10.1016\/j.ejmech.2018.08.037_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2010.04.062","article-title":"Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin","volume":"641","author":"Liu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fphar.2017.00476","article-title":"Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.08.037_bib70","first-page":"1133","article-title":"Proteasome inhibitor YSY01A enhances cisplatin cytotoxicity in cisplatin-resistant human ovarian cancer cells","volume":"7","author":"Huang","year":"2016","journal-title":"J.\u00a0Canc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:55:22Z","timestamp":1759326922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418307037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":70,"alternative-id":["S0223523418307037"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.037","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}